Cathepsin C-IN-5 |
| Catalog No.GC65998 |
Cathepsin C-IN-5(화합물 SF38)는 IC50이 59.9 nM, 4.26 μM, >5 μM, >5 μM, >5 &858888인 강력하고 선택적인 경구 활성 Cathepsin C 억제제입니다. 821d96072c2d58d8970e76f526b0f6b8Cat C, Cat L, Cat S, Cat B, Cat K. 821d96072c2d58d8970e76f526b0f6b8Cathepsin C-IN-5는 골수와 혈액에서 Cat C 활성을 억제합니다. 821d96072c2d58d8970e76f526b0f6b8Cathepsin C-IN-5는 NSP(호중구 세린 프로테아제)의 활성화를 감소시킵니다. 821d96072c2d58d8970e76f526b0f6b8Cathepsin C-IN-5는 항염 작용을 나타냅니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2825567-97-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cathepsin C-IN-5 (compound SF38) is a potent, selective and orally active Cathepsin C inhibitor with IC50s of 59.9 nM, 4.26 µM, >5 µM, >5 µM, >5 µM for Cat C, Cat L, Cat S, Cat B, Cat K, respectively. Cathepsin C-IN-5 inhibits the Cat C activity in bone marrow and blood. Cathepsin C-IN-5 decreases the activation of NSPs (neutrophil serine proteases). Cathepsin C-IN-5 shows anti-inflammatory activity[1].
Cathepsin C-IN-5 (compound SF38) shows inhibition in THP-1 and U937 cells with IC50s of 115.4, 70.2 nM, respectively[1].
Cathepsin C-IN-5 (1500 mg/kg) shows no significant weight loss or toxic reaction within 7 days after the administration in ICR mice[1].
Cathepsin C-IN-5 (10 mg/kg for p.o.; 2 mg/kg for i.v.) shows good bioavailability with F=42.07%[1].
Cathepsin C-IN-5 (2, 10, 50 mg/kg; p.o.) shows effective antiinflammatory activity and potential protective effect in an animal model of ALI[1].
| Animal Model: | C57BL/6 male mice (acute lung injury (ALI) mice model)[1] |
| Dosage: | 2, 10, 50 mg/kg (one hour after administration, received LPS (20 mg/kg)) |
| Administration: | P.o. |
| Result: | Decreased the levels of proinflammatory cytokines (TNF-a, IL-6, and GM-CSF) and increased the the concentration of the anti-inflammatory cytokine (IL-10) in a dose-dependent manner. |
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *